Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report

Helicobacter

Volumn 1, Issue 4, 1996, Pages 251-255

  Schwartz, Howard ^a   Krause, R ^b   Siepman, Nancy ^c   Haber, Marian ^d   Weissfeld, Alice ^e   Kidd, S ^c   Rose, Pamela ^c   Sahba, B ^b  

^a S Florida Ctr for Digest Diseases   (United States)

^b TAP Holdings ^*

^c TAP Holdings Limited   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e Microbiology Specialists Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; CLARITHROMYCIN; DRUG DERIVATIVE; ENZYME INHIBITOR; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIARRHEA; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; DRUG SCREENING; FEMALE; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; SAFETY; TASTE DISORDER; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; CLARITHROMYCIN; DIARRHEA; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; FEMALE; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; SAFETY; TASTE DISORDERS; TREATMENT OUTCOME;

EID: 0030308983     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1996.tb00047.x     Document Type: Article

References (27)

1. Borody T, Andrews P, Brandi S, et al. Relevance of in-vitro metronidazole resistance to H. pylori eradication and eradication failures [abstract]. Gastroenterology 1993;104:A44.
2. Sobala GM, George R. Tompkins D et al. Spontaneous healing of duodenal ulcers alter eradication of H. pylori [abstract] Ir J Med Sci 1992;161 (suppl 10):5.
3. Bell GD, Powell K, Burridge SM, et al. Experience with triple therapy anti- Helicobacter pylori eradication therapy: Side effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6:427-35.
4. Burette A, Glupczynski Y, DePrez C, Ramdani B. Two week combination therapies with tetracycline are less effective than similar regimens with amoxicillin [abstract]. Acta Gastroenterol Belg 1993; 56(suppl):131.
5. Rauws EAJ, Lagenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic active antral gastritis. Gastroenterology 1988;94:33-40.
6. Burette A, Glupczynski Y, DePrez C, et al. Evaluation of various multi-drug eradication regimens for H. pylori. Eur J Gastroenterol Hepatol 1992; 4:817-23.
7. Rautelin H, Seppala K, Renkonen OV, et al. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992;36:163-6.
8. Labenz J, Ruhl GH, Stolte M. et al. Efficacy of one-week triple therapy to cure H. pylori infection [abstract 364]. Am J Gastroenterol 1994, 89 (suppl):1376.
9. Buckley M, Xia HX, Hyde D, O'Morain C. A cost-effective. European approach to H. pylori eradication [abstract 363]. Gut 1995;37(suppl 1):A91.
10. Bazzoli F, Zagari RM, Fossi S, et al. Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori [abstract 317]. Am J Gastroenterol 1994:89(suppl): 1364.
11. Bazzoli F. Guillini S, Zagari RM, et al. Effect of omeprazole and clarithromycin plus tinidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer [abstract 18]. Gut 1995;37(suppl I):A5.
12. Dalia Libera M, Pazzi P, Carli G et al. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication. Aliment Pharmacol Ther 1996; 10:203-6.
13. Jaup BH, Norrby A. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection [abstract 170]. Gut 1995; 37(suppl 1):A43.
14. Jaup BH, Norrby A. Low-dose short-term triple therapy for cure of Helicobacter pylori: Infection and healing of peptic ulcers. Am J Gastroenterol 1995; 90:943-5.
15. Xia HX, Buckley M, Hyde D et al. Effects of antibiotic-resistance in clarithromycin-combined triple therapy for Helicobacter pylori [abstract 218]. Gut 1995;37(suppl 1):A55.
16. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995;7:835-40.
17. Lamouliatte HC, Cayla R, Megraud F, et al. Amoxicillin-clarithromycin-omeprazole: The best therapy for Helicobacter pylori infection [abstract]? Acta Gastroenterol Bel 1993:56(suppl): 140.
18. Moayyedi P, Tompkins DS, Axon ATR. Efficacy of ten days of clarithromycin, amoxycillin, and omeprazole in eradicating Helicobacter pylori infection [abstract 176]. Gut 1995;37(suppl 1):A44.
19. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One-week low-dose triple therapy for eradication of H. pylori: A multicentre randomised trial [abstract]. Gut 1996;38(suppl 1):A1.
20. Lind T, Veldhuyzen van Zanten SJO, Ungfe P, et al. The MACH 1 study: Optimal one-week treatment for H. pylori defined [abstract]. Gut 1995; 37(suppl 1):A4.
21. Goddard AF, Logan RP, Tonge KA, et al. Eradication of H. pylori infection using clarithromycin, omeprazole, and amoxycillin for one week [abstract]. Gut 1995;37(suppl 1):A88.
22. Graham KS, Malaty H. El-Zimaity HM, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gasteroenterol 1995;90:1415-18.
23. 13C-UBT and monoclonal H. pylori antibody testing. J Clin Gastroenterol 1995; 20(suppl. 2):S118-20.
24. Harris AW, Gummett PA. Logan RPH, et al. Eradication of Helicobacter pylori with lansoprazole and clarithromycin. Aliment Pharmacol Ther 1995; 9:201-4.
25. Logan RPH, Gummett PA, Schaufelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994; 35: 323-6.
26. Adamek RJ, Suerbaum S, Pfaffenbach B, Wegener M, Opferkuch W. Primary and acquired H. pylori resistance to clarithromycin, metronidazole, and amoxicillin [abstract 3926). In: Program and Abstracts of Digestive Diseases Week. San Francisco; 1996;A-982.
27. Reddy R, Osato M, Gutierrez O, Kim JG, Graham DY. Metronidazole resistance is high in Korea and Columbia and appears to be rapidly increasing in the U.S. [abstract 3930]. In: Program and Abstracts of Digestive Diseases Week. San Francisco; 1996; A-983.